AIG
AMRX icon

American International Group’s Amneal Pharmaceuticals AMRX Stock Holding History

American International Group’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-60,076
Closed -$364K – 152
2024
Q1 		$364K Sell
60,076
-516
-0.9% -$2.91K ﹤0.01% 1816
2023
Q4 		$368K Sell
60,592
-245
-0.4% -$1.09K ﹤0.01% 1831
2023
Q3 		$257K Buy
60,837
+2,164
+4% +$8.07K ﹤0.01% 1982
2023
Q2 		$182K Buy
58,673
+8,968
+18% +$19.1K ﹤0.01% 2224
2023
Q1 		$69.1K Buy
49,705
+989
+2% +$1.97K ﹤0.01% 2616
2022
Q4 		$96.9K Sell
48,716
-177
-0.4% -$397 ﹤0.01% 2528
2022
Q3 		$99K Buy
48,893
+690
+1% +$1.93K ﹤0.01% 2556
2022
Q2 		$153K Sell
48,203
-1,306
-3% -$4.73K ﹤0.01% 2353
2022
Q1 		$206K Sell
49,509
-3,484
-7% -$15.4K ﹤0.01% 2216
2021
Q4 		$254K Sell
52,993
-1,585
-3% -$7.9K ﹤0.01% 2224
2021
Q3 		$291K Sell
54,578
-1,298
-2% -$6.53K ﹤0.01% 2198
2021
Q2 		$286K Sell
55,876
-1,930
-3% -$11K ﹤0.01% 2282
2021
Q1 		$389K Buy
57,806
+152
+0.3% +$842 ﹤0.01% 1967
2020
Q4 		$263K Sell
57,654
-1,655
-3% -$7.33K ﹤0.01% 2131
2020
Q3 		$230K Sell
59,309
-1,347
-2% -$5.76K ﹤0.01% 2056
2020
Q2 		$289K Sell
60,656
-9,331
-13% -$38.4K ﹤0.01% 1904
2020
Q1 		$244K Sell
69,987
-4,044
-5% -$17.1K ﹤0.01% 1796
2019
Q4 		$357K Buy
74,031
+14,867
+25% +$51.7K ﹤0.01% 1881
2019
Q3 		$172K Sell
59,164
-412
-0.7% -$1.44K ﹤0.01% 2274
2019
Q2 		$427K Buy
59,576
+4,144
+7% +$42.4K ﹤0.01% 1790
2019
Q1 		$785K Sell
55,432
-1,795
-3% -$23.7K ﹤0.01% 1459
2018
Q4 		$774K Sell
57,227
-441
-0.8% -$7.95K ﹤0.01% 1412
2018
Q3 		$1.28M Buy
57,668
+1,039
+2% +$21.9K ﹤0.01% 1281
2018
Q2 		$929K Buy
+56,629
New +$994K ﹤0.01% 1433

Other funds holding AMRX

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American International Group's AMRX Position: Q2 2024 in Review

American International Group sold out of Amneal Pharmaceuticals (AMRX) in Q2 2024, closing a stake of 60,076 shares — an estimated $364K sold.

American International Group first reported a position in AMRX in Q2 2018 and held it in 24 quarters. The position peaked at $1.28M in Q3 2018. 181 funds tracked by Wall St. Rank hold AMRX as of Q2 2024.

  • American International Group reported no remaining Amneal Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 60,076 Amneal Pharmaceuticals shares in Q2 2024, an estimated $364K.
  • American International Group first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 24 quarters.
  • American International Group's Amneal Pharmaceuticals position peaked at $1.28M in Q3 2018.
  • 181 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.